Hall, Render, Killian, Heath & Lyman P.C., which represents 340B providers, urged drugmakers to reject new 340B ESP terms and conditions.

News Alert

340B Covered Entities Threaten Action Against Drugmakers Over New Reporting Requirements

A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.